non-small cell lung cancer (NSCLC)non-smokerssmokersThe 100th annual meeting of the American Association for Cancer Research (AACR) took place in Denver on 1822 April 2009 which brought together over 17,000 researchers from basic, translational and clinical cancer studies who exchanged and ...
aAs a possible participant in Study I3Y-MC-JPBK, we are inviting you to provide a sample of your stored tumor tissue for research on lung cancer. 作为一个可能的参加者在研究I3Y-MC-JPBK,我们邀请您为对肺癌的研究提供您的被存放的肿瘤组织样品。[translate]...
The International Epidemiology of Lung Cancer: geographical distribution and secular trends. A higher proportion of lung cancer cases are attributable to nonsmoking causes within less developed countries, particularly among women. Worldwide, the ... DR Youlden,SM Cramb,PD Baade - 《Journal of ...
Analysis of circulating tumour DNA (ctDNA) is commonly used for molecular profiling in patients with advanced-stage non-small-cell lung cancer (NSCLC). The authors of this Review summarize the available evidence on the potential utility of incorporating ctDNA in the management of those with early...
Heather Wakelee, MD, associate professor of Medicine (Oncology), Stanford University Medical Center, discusses the evolving role of bevacizumab (Avastin) in the treatment of patients with non–small cell lung cancer.
Get the latest lung cancer research and breakthroughs in lung cancer treatment, including maintenance therapies, advanced detection methods, and more.
Herein, we highlight discussion from the 9th annual Lung Cancer Congress in June 2008, focused on advanced-stage non–small-cell lung cancer (NSCLC). Many studies are looking at the addition of targeted agents such as bevacizumab, cetuximab, vascular endothelial growth factor receptor inhibitors, ...
Novel CME activities delving into topics and critical aspects of clinical cancer management. Meet The Professor: Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review (Webinar Audio Proceedings)December 2024 ...
Clinical research on pemetrexed combined with navelbine in the treatment of elderly patients with advanced non-small-cell lung cancer 来自 Semantic Scholar 喜欢 0 阅读量: 31 作者:MY Wang,HT Zhao,GF Sun 摘要: Objective To observe the therapeutic effectiveness and toxicity of pemetrexed combined with...
Biomarkers are specific changes in a patient’s lung cancer cells. This could mean there is a mutation, addition, deletion, or rearrangement of DNA that is causing the lung cancer cells to grow uncontrollably. Based on what is found in the biomarker testing process, the oncologist can choose ...